• Home
  • Mithra Biotechnology Inc.
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 8F2
Book a meeting

Mithra Biotechnology Inc.

About Mithra Biotechnology Inc.

Mithra Biotechnology Inc. provides integrated solutions for biosimilar development, supporting clients from analytical characterization and similarity assessment to bioanalysis and PK comparability. Our fit-for-purpose solutions connect analytical and clinical data to support efficient development and regulatory submission. Beyond biosimilars, Mithra offers expertise in complex modalities, including ADCs and bispecific antibodies. With profound experience in bioequivalence study, protein characterization and bioanalysis, we combine scientific expertise, regulatory knowledge, and international quality standards to deliver reliable solutions from analytical similarity to PK comparability.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 8F2
  • Country/Region:
    Taiwan
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Research Organisation
Contact info
  • +886-2-2696-2669
  • Website
  • 7F., No. 104, Sec.1, Xintai 5th Rd., Xizhi Dist., 221411, New Taipei City, Taiwan, Taiwan
Show contact info Hide contact info

Products from Mithra Biotechnology Inc. (3)

  • Integrated Biosimilar Development Solutions

    Product Integrated Biosimilar Development Solutions

    Comprehensive support for biosimilar development, from protein characterization and analytical similarity assessment to comparative PK studies. Our integrated approach connects analytical and bioanalytical data to support scientific evaluation, regulatory strategy, and efficient clinical development.
  • ADC Solutions

    Product ADC Solutions

    Integrated analytical and bioanalytical solutions for ADC development, covering molecular characterization, conjugation assessment, DAR, payload distribution, and serum/plasma stability. Our bioanalysis capabilities include ADC, total antibody, conjugated antibody, and free payload analysis to support PK a...
  • PK Modeling & E-R Analysis

    Product PK Modeling & E-R Analysis

    Model-informed solutions to support FIH dose selection and clinical dose optimization, integrating PK, PD, safety, and efficacy data. Our capabilities include PK modeling, exposure–response (E-R) analysis, and RP2D dose optimization, providing quantitative insights for informed dose decisions throughout cl...